Related Experiment Videos
p21ras is modified by a farnesyl isoprenoid
P J Casey1, P A Solski, C J Der
1Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235.
Summary
Oncogenic Ras proteins associate with cell membranes through a Cys-Ali-Ali-Xaa sequence. This study reveals Ras proteins undergo farnesylation, similar to yeast mating factors, impacting membrane binding and cell transformation.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Oncogenic Ras proteins require membrane association for cellular transformation.
- Ras proteins are synthesized as cytosolic precursors and processed to mature, membrane-localized forms.
- A conserved Cys-Ali-Ali-Xaa motif at the Ras COOH terminus is critical for processing.
Purpose of the Study:
- To investigate the post-translational modification of Ras proteins at their COOH terminus.
- To determine if Ras proteins are modified by palmitoylation or isoprenoid addition, like yeast mating factors.
- To explore the role of this modification in Ras membrane association and transforming activity.
Main Methods:
- Comparative analysis of Ras protein processing with yeast a-factor mating hormone precursor.
- Investigating the COOH-terminal Cys-Ali-Ali-Xaa sequence for post-translational modifications.
- Assessing the impact of identified modifications on Ras membrane localization and biological function.
Main Results:
- Ras proteins, analogous to yeast peptides, undergo farnesylation at the COOH-terminal cysteine.
- This farnesylation appears to be a key modification, rather than palmitoylation, for Ras processing.
- Farnesylation is implicated as crucial for Ras membrane association and its oncogenic transforming activity.
Conclusions:
- The Cys-Ali-Ali-Xaa motif signals farnesylation for Ras proteins, a modification shared with yeast mating factors.
- Farnesylation is essential for the proper membrane localization and oncogenic function of Ras proteins.
- This finding clarifies Ras protein processing and suggests potential therapeutic targets.